Skip to main content
OpenTrials
Completed

NCT Number: NCT06169462

Comparison of Pericapsular Nerve Group Block With Suprainguinal Fascia Compartment Block in Hip Fractures

Ultrasound-guided Supra-inguinal Fascia Iliaca compartment Block (SIFCB) and Pericapsular Nerve Group Block (PENG) are increasingly being used for postoperative analgesia for hip surgery. The postoperative analgesic efficacy of SIFCB added to PENG block in elderly hip fracture patients will be evaluated. Postoperative opioid consumption and quality of recovery will also be evaluated.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Hip Fractures Femoral Fractures Fractures, Bone Hip Injuries Leg Injuries Wounds and Injuries

Age range

65 year–90 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Karaman Training and Research Hospital

Karaman, Karaman/Merkez, 70200, Turkey (Türkiye)

About this study

The study was conducted as a retrospective cohort feasibility design within a tertiary hospital. Patient records and electronic data systems were used to gather the required data for analysis. Before surgery, a carefully selected cohort of patients who underwent PENG block and PENG block added SIFCB were included in the study.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Physical status according to American Society of Anesthesiologists (ASA ) I-III

Exclusion criteria

  • Previous operation on the same hip
  • Hepatic or renal insufficiency
  • Patients undergoing general anesthesia
  • Allergy or intolerance to one of the study medications
  • BMI >40
  • ASA IV

Treatment and study plan

PENG block

Procedure

Patients underwent ultrasound-guided PENG Block for older adult patients surgery for hip fracture. Patients who received opioids as a rescue analgesic during postoperative pain management on selected dates will be included in the study.

Other names: Drug

PENG block+ SIFCB

Procedure

Patients underwent ultrasound-guided PENG Block+ SIFCB for older adult patients surgery for hip fracture. Patients who received opioids as a rescue analgesic during postoperative pain management on selected dates will be included in the study.

Other names: Drug

Primary outcomes

  1. Opioid consumption

    Time frame: Postoperative 48th hour

    If the patient's Numerical Rating Scale (NRS) score is equal to or above 4, tramadol 50 mg IV or oxycodone 5 mg orally every 4 hours will be administered as rescue analgesia.

Secondary outcomes

  1. Numerical Rating Scale (NRS) scores

    Time frame: Postoperative 48th hour

    Range 0-10, 0=no pain, 10=the worse pain ever

  2. Quality of Recovery 15 Score

    Time frame: Postoperative day 1 and 1 month

    Quality of Recovery (QoR)-15 survey.Minimum value: 0, Maximum value: 150, higher scores mean better

  3. Postoperative complications

    Time frame: 24 hours

    Presence of postoperative nausea, vomiting, pruritus, urinary retention, respiratory depression

  4. Mobilization time

    Time frame: 24 hours

    Mobilization time

Sponsors and collaborators

Lead sponsor

Karaman Training and Research Hospital

Other

Registry information

Official study title

Comparison of Pericapsular Nerve Group (PENG) Block Alone Versus Combined With Suprainguinal Fascia Compartment Block (SIFCB) for Postoperative Analgesia and Quality of Recovery in Older Adult Patients With Hip Fractures

Important dates

Study start
2023
Primary completion
2023
Study completion
2023
First posted
Dec 13, 2023
Registry last updated
Dec 14, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.